Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
Duke is among a number of leading research institutions nationwide making progress in developing cancer treatments that are expected to replace current treatment methods, which have toxic side effects and uncertain results. Broadly classified as immunotherapies, the new wave of treatments create customized medications using the patient’s own cells, or train the patient’s immune system to detect cancer, which is difficult to recognize by disease-hunting defender cells because cancer is an extension of the patient’s body, not a foreign invader.
Moderator cut: too long a quote, 1-2 sentences and link.
Last edited by SouthernBelleInUtah; 09-21-2017 at 01:54 PM..
This is the Duke Medical School PR department in high gear. I really liked this sentence "Their first clinical trial, began in 2012, was designed to show the treatment is safe, and was tested on about 60 patients to determine a safe dose, but it did not prevent all the enrolled patients from succumbing to brain cancer." That's typically the way with these things.
The problem to date with these approaches has been durability of response since the cancer cells are rapidly mutating.